%PDF-1.4
%
240 0 obj
<>
endobj
230 0 obj
<>
endobj
229 0 obj
<>stream
application/pdf
Baricitinib in patients with inadequate response or intolerance to conventional synthetic DMARDs: results from the RA-BUILD study
2016-11-08T20:58:43+05:30
Arbortext Advanced Print Publisher 10.0.1465/W Unicode
2024-03-29T02:52:33-07:00
2024-03-29T02:52:33-07:00
Acrobat Distiller 8.1.0 (Windows)
uuid:d351eefc-ebb8-46e2-af15-019755aa26bc
uuid:d609df1e-1dd1-11b2-0a00-81004867efff
endstream
endobj
241 0 obj
<>
endobj
156 0 obj
<>
endobj
227 0 obj
<>
endobj
5 0 obj
<>
endobj
226 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]/Properties<>>>/Rotate 0/Thumb 172 0 R/Type/Page>>
endobj
1 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 2 0 R/Type/Page>>
endobj
28 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text/ImageB]/XObject<>>>/Rotate 0/Thumb 29 0 R/Type/Page>>
endobj
49 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 50 0 R/Type/Page>>
endobj
63 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text/ImageB]/XObject<>>>/Rotate 0/Thumb 64 0 R/Type/Page>>
endobj
69 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text/ImageC]/XObject<>>>/Rotate 0/Thumb 70 0 R/Type/Page>>
endobj
83 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 84 0 R/Type/Page>>
endobj
110 0 obj
<>/ExtGState<>/Font<>/ProcSet[/PDF/Text]>>/Rotate 0/Thumb 111 0 R/Type/Page>>
endobj
339 0 obj
<>stream
HW]sJ}Уز30c?v>beE
. 9_=À@N[y9O͏+onCu4{#6EPJ(`| Ft&)U:,L\>R?âѸXo;tu5˙\*/ኙιs4ǟh|],aܕpZ'Pzys8O2aڮc|.D/zUuZQr,!wrCE
|Ψw߮.td1<<]a]qVPk-u;BbgIJe|zRf7gyaj>y~) C~qdqSF{H fJuts*usx{`^Bg8|CN}"`Ac!U]o#)T6)vjEuSScg "0D\] I^_f(}_k|q_\2ܤ4Jj̘+9iOɪ_uC!=d'9yj n:1z6 ۙ7>]<ߐA,
lP}>Ȗ6ؤbs,S3H!dFMxи4',;japox!5)BWJ0"*@oe;訡i[R%t